Press Release: PNP Therapeutics : GeoVax Expands Immuno-Oncology Pipeline with Acquisition of Clinical-Stage Cancer Program
License of Gedeptin® Adds Orphan Drug Clinical Program for Treatment of Advanced Head and Neck Cancers ATLANTA, GA, Sept. 28, 2021 (GLOBE NEWSWIRE) -- via
Read full article »
PNP Therapeutics is a biopharmaceutical company that focuses on developing platform technology and proprietary products for the treatment of cancer.
Read more